
GPhC-registered Independent Prescribing pharmacist with specialist expertise in obesity medicine, GLP-1 receptor agonist therapies, biologics and immune-mediated inflammatory and metabolic diseases. Currently delivering obesity care within a leading digital healthcare organisation whilst bringing over seven years of NHS experience across endocrinology, rheumatology, immunology and high-cost medicines. Experienced in translating complex clinical evidence into meaningful scientific discussions, supporting evidence-based decision making and generating real-world insights to optimise patient outcomes. Strong track record of engaging healthcare professionals, delivering medical education, implementing innovative treatment pathways and collaborating across multidisciplinary stakeholder groups.
Thrive in dynamic, fast-paced environments, with a proven ability to solve problems and think strategically.
Obesity medicine and GLP-1 therapies expertise
Passion for endocrinology and metabolic medicine
Scientific exchange and communication
Medical education and training
Stakeholder engagement and influence
Clinical evidence appraisal
Cross-functional collaboration
Knowledge of financial and commercial strategy within the NHS
Medical governance and patient safety
Proactive
Independent & team-worker
Supported clinical trials involving baricitinib and tocilizumab, including patient identification, protocol implementation, safety monitoring and evidence generation.
Available upon request